Shares of Salarius Pharmaceuticals (NASDAQ:SLRX) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 72.73% year over…
Salarius Pharmaceuticals: Q1 Earnings Insights
2021-05-12T20:29:53-04:00May 12th, 2021|